Laura M. Lashinger, Ph.D.
Affiliations: | 2005 | The University of Texas Graduate School of Biomedical Sciences at Houston |
Area:
Cell Biology, Molecular Biology, OncologyGoogle:
"Laura Lashinger"Parents
Sign in to add mentor| David J. McConkey | grad student | 2005 | The University of Texas Graduate School of Biomedical Sciences at Houston | |
| (Bortezomib modulates TRAIL sensitivity in human bladder and prostate cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Coleman M, Liu K, Tang X, et al. (2020) Dietary β-Hydroxy-β-Methylbutyrate Supplementation Promotes PDAC Response to Gemcitabine and Immunotherapy Response in Obese Mice Current Developments in Nutrition. 4: 313-313 |
| Coleman MF, Liu KA, Tang X, et al. (2019) Abstract 1090: β-Hydroxy-β-Methylbutyrate supplementation preserves muscle mass and reduces tumor growth in obese mice Cancer Research. 79: 1090-1090 |
| Lashinger LM, O'Flanagan CH, Dunlap SM, et al. (2016) Starving cancer from the outside and inside: separate and combined effects of calorie restriction and autophagy inhibition on Ras-driven tumors. Cancer & Metabolism. 4: 18 |
| Devlin KL, Sanford T, Harrison LM, et al. (2016) Stage-Specific MicroRNAs and Their Role in the Anticancer Effects of Calorie Restriction in a Rat Model of ER-Positive Luminal Breast Cancer. Plos One. 11: e0159686 |
| Naguib YW, Lansakara-P D, Lashinger LM, et al. (2016) Synthesis, Characterization, and In Vitro and In Vivo Evaluations of 4-(N)-Docosahexaenoyl 2', 2'-Difluorodeoxycytidine with Potent and Broad-Spectrum Antitumor Activity. Neoplasia (New York, N.Y.). 18: 33-48 |
| Cifarelli V, Lashinger LM, Devlin KL, et al. (2015) Metformin and Rapamycin Reduce Pancreatic Cancer Growth in Obese Prediabetic Mice by Distinct MicroRNA-Regulated Mechanisms. Diabetes. 64: 1632-42 |
| Lashinger LM, Rossi EL, Hursting SD. (2014) Obesity and resistance to cancer chemotherapy: interacting roles of inflammation and metabolic dysregulation. Clinical Pharmacology and Therapeutics. 96: 458-63 |
| Harvey AE, Lashinger LM, Hays D, et al. (2014) Calorie restriction decreases murine and human pancreatic tumor cell growth, nuclear factor-κB activation, and inflammation-related gene expression in an insulin-like growth factor-1-dependent manner. Plos One. 9: e94151 |
| Liu KA, Lashinger LM, Rasmussen AJ, et al. (2014) Leucine supplementation differentially enhances pancreatic cancer growth in lean and overweight mice. Cancer & Metabolism. 2: 6 |
| Lashinger LM, Ford NA, Hursting SD. (2014) Interacting inflammatory and growth factor signals underlie the obesity-cancer link. The Journal of Nutrition. 144: 109-13 |